Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Nov;70(5):905–907. doi: 10.1038/bjc.1994.418

Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12.

P Englefield 1, W D Foulkes 1, I G Campbell 1
PMCID: PMC2033554  PMID: 7947096

Abstract

Frequent loss of heterozygosity (LOH) has been reported on 22q in ovarian carcinoma, implying the presence of a tumour-suppressor gene. The neurofibromatosis type 2 gene (NF2) at 22q12 is a plausible candidate. Analysis of 9 of the 17 exons of NF2 by single-strand conformational polymorphism (SSCP) in 67 ovarian carcinomas did not detect any somatic mutations, suggesting that NF2 is not involved in the pathogenesis of ovarian carcinoma. LOH data support this conclusion and that the putative tumour-suppressor gene lies distal to NF2, beyond D22S283.

Full text

PDF
905

Images in this article

906Figure 1
on p.906

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan G. J., Cottrell S., Trowsdale J., Foulkes W. D. Loss of heterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and is not associated with mutations in APC at 5q21-22. Hum Mutat. 1994;3(3):283–291. doi: 10.1002/humu.1380030317. [DOI] [PubMed] [Google Scholar]
  2. Arakawa H., Hayashi N., Nagase H., Ogawa M., Nakamura Y. Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Hum Mol Genet. 1994 Apr;3(4):565–568. doi: 10.1093/hmg/3.4.565. [DOI] [PubMed] [Google Scholar]
  3. Bianchi A. B., Hara T., Ramesh V., Gao J., Klein-Szanto A. J., Morin F., Menon A. G., Trofatter J. A., Gusella J. F., Seizinger B. R. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nat Genet. 1994 Feb;6(2):185–192. doi: 10.1038/ng0294-185. [DOI] [PubMed] [Google Scholar]
  4. Buetow K. H., Weber J. L., Ludwigsen S., Scherpbier-Heddema T., Duyk G. M., Sheffield V. C., Wang Z., Murray J. C. Integrated human genome-wide maps constructed using the CEPH reference panel. Nat Genet. 1994 Apr;6(4):391–393. doi: 10.1038/ng0494-391. [DOI] [PubMed] [Google Scholar]
  5. Campbell I. G., Nicolai H. M., Foulkes W. D., Senger G., Stamp G. W., Allan G., Boyer C., Jones K., Bast R. C., Jr, Solomon E. A novel gene encoding a B-box protein within the BRCA1 region at 17q21.1. Hum Mol Genet. 1994 Apr;3(4):589–594. doi: 10.1093/hmg/3.4.589. [DOI] [PubMed] [Google Scholar]
  6. Chen L. C., Kurisu W., Ljung B. M., Goldman E. S., Moore D., 2nd, Smith H. S. Heterogeneity for allelic loss in human breast cancer. J Natl Cancer Inst. 1992 Apr 1;84(7):506–510. doi: 10.1093/jnci/84.7.506. [DOI] [PubMed] [Google Scholar]
  7. Cliby W., Ritland S., Hartmann L., Dodson M., Halling K. C., Keeney G., Podratz K. C., Jenkins R. B. Human epithelial ovarian cancer allelotype. Cancer Res. 1993 May 15;53(10 Suppl):2393–2398. [PubMed] [Google Scholar]
  8. Dodson M. K., Hartmann L. C., Cliby W. A., DeLacey K. A., Keeney G. L., Ritland S. R., Su J. Q., Podratz K. C., Jenkins R. B. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Cancer Res. 1993 Oct 1;53(19):4456–4460. [PubMed] [Google Scholar]
  9. Foulkes W. D., Black D. M., Stamp G. W., Solomon E., Trowsdale J. Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma. Int J Cancer. 1993 May 8;54(2):220–225. doi: 10.1002/ijc.2910540210. [DOI] [PubMed] [Google Scholar]
  10. Foulkes W. D., Campbell I. G., Stamp G. W., Trowsdale J. Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer. Br J Cancer. 1993 Feb;67(2):268–273. doi: 10.1038/bjc.1993.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Foulkes W. D., Englefield P., Campbell I. G. Mutation analysis of RASK and the 'FLR exon' of NF1 in sporadic ovarian carcinoma. Eur J Cancer. 1994;30A(4):528–530. doi: 10.1016/0959-8049(94)90432-4. [DOI] [PubMed] [Google Scholar]
  12. Foulkes W. D., Ragoussis J., Stamp G. W., Allan G. J., Trowsdale J. Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br J Cancer. 1993 Mar;67(3):551–559. doi: 10.1038/bjc.1993.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lekanne Deprez R. H., Bianchi A. B., Groen N. A., Seizinger B. R., Hagemeijer A., van Drunen E., Bootsma D., Koper J. W., Avezaat C. J., Kley N. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet. 1994 Jun;54(6):1022–1029. [PMC free article] [PubMed] [Google Scholar]
  14. Li Y., Bollag G., Clark R., Stevens J., Conroy L., Fults D., Ward K., Friedman E., Samowitz W., Robertson M. Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell. 1992 Apr 17;69(2):275–281. doi: 10.1016/0092-8674(92)90408-5. [DOI] [PubMed] [Google Scholar]
  15. Lindblom A., Skoog L., Rotstein S., Werelius B., Larsson C., Nordenskjöld M. Loss of heterozygosity in familial breast carcinomas. Cancer Res. 1993 Sep 15;53(18):4356–4361. [PubMed] [Google Scholar]
  16. Matise T. C., Perlin M., Chakravarti A. Automated construction of genetic linkage maps using an expert system (MultiMap): a human genome linkage map. Nat Genet. 1994 Apr;6(4):384–390. doi: 10.1038/ng0494-384. [DOI] [PubMed] [Google Scholar]
  17. Miyaki M., Seki M., Okamoto M., Yamanaka A., Maeda Y., Tanaka K., Kikuchi R., Iwama T., Ikeuchi T., Tonomura A. Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis. Cancer Res. 1990 Nov 15;50(22):7166–7173. [PubMed] [Google Scholar]
  18. Okamoto M., Sasaki M., Sugio K., Sato C., Iwama T., Ikeuchi T., Tonomura A., Sasazuki T., Miyaki M. Loss of constitutional heterozygosity in colon carcinoma from patients with familial polyposis coli. Nature. 1988 Jan 21;331(6153):273–277. doi: 10.1038/331273a0. [DOI] [PubMed] [Google Scholar]
  19. Osborne R. J., Leech V. Polymerase chain reaction allelotyping of human ovarian cancer. Br J Cancer. 1994 Mar;69(3):429–438. doi: 10.1038/bjc.1994.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Rubio M. P., Correa K. M., Ramesh V., MacCollin M. M., Jacoby L. B., von Deimling A., Gusella J. F., Louis D. N. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res. 1994 Jan 1;54(1):45–47. [PubMed] [Google Scholar]
  21. Ruttledge M. H., Sarrazin J., Rangaratnam S., Phelan C. M., Twist E., Merel P., Delattre O., Thomas G., Nordenskjöld M., Collins V. P. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet. 1994 Feb;6(2):180–184. doi: 10.1038/ng0294-180. [DOI] [PubMed] [Google Scholar]
  22. Sainz J., Nechiporuk A., Kim U. J., Simon M. I., Pulst S. M. CA-repeat polymorphism at the D22S430 locus adjacent to NF2. Hum Mol Genet. 1993 Dec;2(12):2203–2203. doi: 10.1093/hmg/2.12.2203. [DOI] [PubMed] [Google Scholar]
  23. Sanson M., Marineau C., Desmaze C., Lutchman M., Ruttledge M., Baron C., Narod S., Delattre O., Lenoir G., Thomas G. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus. Hum Mol Genet. 1993 Aug;2(8):1215–1220. doi: 10.1093/hmg/2.8.1215. [DOI] [PubMed] [Google Scholar]
  24. Sato T., Saito H., Morita R., Koi S., Lee J. H., Nakamura Y. Allelotype of human ovarian cancer. Cancer Res. 1991 Oct 1;51(19):5118–5122. [PubMed] [Google Scholar]
  25. Sato T., Tanigami A., Yamakawa K., Akiyama F., Kasumi F., Sakamoto G., Nakamura Y. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res. 1990 Nov 15;50(22):7184–7189. [PubMed] [Google Scholar]
  26. Sheffield V. C., Beck J. S., Kwitek A. E., Sandstrom D. W., Stone E. M. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics. 1993 May;16(2):325–332. doi: 10.1006/geno.1993.1193. [DOI] [PubMed] [Google Scholar]
  27. Takahashi K., Kudo J., Ishibashi H., Hirata Y., Niho Y. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma. Hepatology. 1993 May;17(5):794–799. [PubMed] [Google Scholar]
  28. Trofatter J. A., MacCollin M. M., Rutter J. L., Murrell J. R., Duyao M. P., Parry D. M., Eldridge R., Kley N., Menon A. G., Pulaski K. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell. 1993 Mar 12;72(5):791–800. doi: 10.1016/0092-8674(93)90406-g. [DOI] [PubMed] [Google Scholar]
  29. Twist E. C., Ruttledge M. H., Rousseau M., Sanson M., Papi L., Merel P., Delattre O., Thomas G., Rouleau G. A. The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet. 1994 Jan;3(1):147–151. doi: 10.1093/hmg/3.1.147. [DOI] [PubMed] [Google Scholar]
  30. Weissenbach J., Gyapay G., Dib C., Vignal A., Morissette J., Millasseau P., Vaysseix G., Lathrop M. A second-generation linkage map of the human genome. Nature. 1992 Oct 29;359(6398):794–801. doi: 10.1038/359794a0. [DOI] [PubMed] [Google Scholar]
  31. Yang-Feng T. L., Han H., Chen K. C., Li S. B., Claus E. B., Carcangiu M. L., Chambers S. K., Chambers J. T., Schwartz P. E. Allelic loss in ovarian cancer. Int J Cancer. 1993 Jun 19;54(4):546–551. doi: 10.1002/ijc.2910540405. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES